Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Achievement and WT1[original query] |
|---|
| Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology reports 2013 May 29 (5): 1867-72. Riera Ludovica, Marmont Filippo, Toppino Daniela, Frairia Chiara, Sismondi Francesca, Audisio Ernesta, Di Bello Cristiana, D'Ardia Stefano, Di Celle Paola Francia, Messa Emanuela, Inghirami Giorgio, Vitolo Umberto, Pich Achil |
| MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin. Oncotarget 2014 Aug 5 (15): 6280-8. Lambert Juliette, Lambert Jérôme, Nibourel Olivier, Pautas Cécile, Hayette Sandrine, Cayuela Jean-Michel, Terré Christine, Rousselot Philippe, Dombret Hervé, Chevret Sylvie, Preudhomme Claude, Castaigne Sylvie, Renneville Ali |
| High EVI1 Expression Predicts Poor Outcomes in Adult Acute Myeloid Leukemia Patients with Intermediate Cytogenetic Risk Receiving Chemotherapy. Medical science monitor : international medical journal of experimental and clinical research 2018 2 24 758-767. Qin Ya-Zhen, Zhao Ting, Zhu Hong-Hu, Wang Jing, Jia Jin-Song, Lai Yue-Yun, Zhao Xiao-Su, Shi Hong-Xia, Liu Yan-Rong, Jiang Hao, Huang Xiao-Jun, Jiang Qi |
| WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia. Clinical lymphoma, myeloma & leukemia 2020 Aug . Šálek Cyril, Vydra Jan, Cerovská Ela, Šestáková Šárka, Ransdorfová Šárka, Válková Veronika, Cetkovský Petr, Remešová Ha |
| High WT1 expression predicted induction chemotherapy failure in acute myeloid leukemia patients with non-favorable cytogenetic risk. Clinical and experimental medicine 2023 1 . Xu Nan, Chen Wen-Min, Li Ling-Di, Long Ling-Yu, Wang Xu, Jiang Qian, Jiang Hao, Huang Xiao-Jun, Qin Ya-Zh |
- Page last reviewed:Feb 1, 2024
- Content source: